Conspiracy Fact or Fiction: "What are US Biological Warfare Researchers Doing in the Ebola Zone?"
Options
cobbland
Members Posts: 3,768 ✭✭✭✭✭
Worth reading if interested:
"Although it may take several decades for the process of transformation to unfold, in time, the art of warfare on air, land, and sea will be vastly different than it is today, and “combat” likely will take place in new dimensions: in space, “cyber-space,” and perhaps the world of microbes...And advanced forms of biological warfare that can “target” specific genotypes may transform biological warfare from the realm of terror to a politically useful tool." (Rebuilding America's Defenses, 72)
****This quote appears on page 60 of the actual document, but page 72 in the pdf file.****
REBUILDING AMERICA’S DEFENSES Strategy, Forces and Resources For a New Century
A Report of The Project for the New American Century
September 2000
West Africa: What are US Biological Warfare Researchers Doing in the Ebola Zone?
By Jon Rappoport
Global Research, August 02, 2014
jonrappoport.wordpress.com/
This is a call for an immediate, thorough, and independent investigation of Tulane University researchers (see here and here) and their Fort Detrick associates in the US biowarfare research community, who have been operating in West Africa during the past several years.
What exactly have they been doing?
Exactly what diagnostic tests have they been performing on citizens of Sierra Leone?
Why do we have reports that the government of Sierra Leone has recently told Tulane researchers to stop this testing?
Have Tulane researchers and their associates attempted any experimental treatments (e.g., injecting monoclonal antibodies) using citizens of the region? If so, what adverse events have occurred?
The research program, occurring in Sierra Leone, the Republic of Guinea, and Liberia—said to be the epicenter of the 2014 Ebola outbreak—has the announced purpose, among others, of detecting the future use of fever-viruses as bioweapons.
Is this purely defensive research? Or as we have seen in the past, is this research being covertly used to develop offensive bioweapons?
For the last several years, researchers from Tulane University have been active in the African areas where Ebola is said to have broken out in 2014.
These researchers are working with other institutions, one of which is USAMRIID, the US Army Medical Research Institute of Infectious Diseases, a well-known center for biowar research, located at Fort Detrick, Maryland.
In Sierra Leone, the Tulane group has been researching new diagnostic tests for hemorrhagic fevers.
Note: Lassa Fever, Ebola, and other labels are applied to a spectrum of illness that result in hemorrhaging.
Tulane researchers have also been investigating the use of monoclonal antibodies as a treatment for these fevers—but not on-site in Africa, according to Tulane press releases.
Here are excerpts from supporting documents.
Tulane University, Oct. 12, 2012, “Dean’s Update: Update on Lassa Fever Research” (.pdf here):
“In 2009, researchers received a five-year $7,073,538 grant from the National Institute of Health to fund the continued development of detection kits for Lassa viral hemorrhagic fever.
“Since that time, much has been done to study the disease. Dr. Robert Garry, Professor of Microbiology and Immunology, and Dr. James Robinson, Professor of Pediatrics, have been involved in the research of Lassa fever. Together the two have recently been able to create what are called human monoclonal antibodies. After isolating the B-cells from patients that have survived the disease, they have utilized molecular cloning methods to isolate the antibodies and reproduce them in the laboratory. These antibodies have been tested on guinea pigs at The University of Texas Medical Branch in Galveston and shown to help prevent them from dying of Lassa fever…
“Most recently, a new Lassa fever ward is being constructed in Sierra Leone at the Kenema Government Hospital. When finished, it will be better equipped to assist patients affected by the disease and will hopefully help to end the spread of it.” [The Kenema Hospital is one of the centers of the Ebola outbreak.]
Here is another release from Tulane University, this one dated Oct. 18, 2007. “New Test Moves Forward to Detect Bioterrorism Threats.”
“The initial round of clinical testing has been completed for the first diagnostic test kits that will aid in bioterrorism defense against a deadly viral disease. Tulane University researchers are collaborating in the project.
“Robert Garry, professor of microbiology and immunology at Tulane University, is principal investigator in a federally funded study to develop new tests for viral hemorrhagic fevers.
“Corgenix Medical Corp., a worldwide developer and marketer of diagnostic test kits, announced that the first test kits for detection of hemorrhagic fever have competed initial clinical testing in West Africa.
“The kits, developed under a $3.8 million grant awarded by the National Institutes of Health, involve work by Corgenix in collaboration with Tulane University, the U.S. Army Medical Research Institute of Infectious Diseases, BioFactura Inc. and Autoimmune Technologies.
“Clinical reports from the studies in Sierra Leone continue to show amazing results,” says Robert Garry, professor of microbiology and immunology at the Tulane University School of Medicine and principal investigator of the grant.
“We believe this remarkable collaboration will result in detection products that will truly have a meaningful impact on the healthcare in West Africa, but will also fill a badly needed gap in the bioterrorism defense.
Comments
-
“…The clinical studies are being conducted at the Mano River Union Lassa Fever Network in Sierra Leone. Tulane, under contract with the World Health Organization, implements the program in the Mano River Union countries (Sierra Leone, Liberia and Guinea) to develop national and regional prevention and control strategies for Lassa fever and other important regional diseases.
“Clinical testing on the new recombinant technology demonstrates that our collaboration is working,” says Douglass Simpson, president of Corgenix. “We have combined the skills of different parties, resulting in development of some remarkable test kits in a surprisingly short period of time. As a group we intend to expand this program to address other important infectious agents with both clinical health issues and threat of bioterrorism such as ebola.”
The third document is found on the Sierra Leone Ministry of Health and Sanitation Facebook page (no login required), dated July 23 at 1:35pm. It lays out emergency measures to be taken. We find this curious statement: “Tulane University to stop Ebola testing during the current Ebola outbreak.”
Why? Are the tests issuing false results? Are they frightening the population? Have Tulane researchers done something to endanger public health?
In addition to an investigation of these matters, another probe needs to be launched into all vaccine campaigns in the Ebola Zone. For example. HPV vaccine programs have been ongoing. Vials of vaccine must be tested to discover ALL ingredients. Additionally, it’s well known that giving vaccines to people whose immune systems are already severely compromised is dangerous and deadly.
Thanks to birdflu666.wordpress.com for discovering hidden elements of the Ebola story.
http://www.globalresearch.ca/what-are-us-biological-warfare-researchers-doing-in-the-ebola-zone/5394582The Troubling Truth Behind the Ebola Outbreak
By Tony Cartalucci
Global Research, April 13, 2014
New Eastern Outlook
In the Guardian’s article, “Panic as deadly Ebola virus spreads across West Africa,” it reports:
Since the outbreak of the deadly strain of Zaire Ebola in Guinea in February, around 90 people have died as the disease has travelled to neighbouring Sierra Leone, Liberia and Mali. The outbreak has sent shock waves through communities who know little of the disease or how it is transmitted. The cases in Mali have added to fears that it is spreading through West Africa.
The Guardian also reported that Médecins Sans Frontières (MSF), also known in English as Doctors Without Borders, had established treatment centers in Guinea, one of which came under attack as locals accused the foreign aid group of bringing the disease into the country. Also under fire is the government of Guinea itself, which has proved incapable of handling the crisis.
This latest outbreak, which has yet to be contained and is being considered by Doctors Without Borders as an “unprecedented epidemic,” illustrates several troubling truths about global health care, emergency response to outbreaks, and the perception many have of a West subjecting the developing world to a “medical tyranny.”
http://www.globalresearch.ca/the-troubling-truth-behind-the-ebola-outbreak/5377653
CNN’s FAREED ZAKARIA GPS features an interview with George Soros, chairman of Soros Fund Management and author of The Tragedy of the European Union (2014). Soros spoke with Fareed about Putin’s actions and intentions in Ukraine, anti-Semitism, and the sense of nationalism on the rise in Ukraine and in Europe.
TRANSCRIPT:
FAREED ZAKARIA, HOST: George Soros has made one of the world's great fortunes betting on global trends. And he is deeply troubled by events and political trends in Ukraine specifically...but Europe more broadly.
He's just back from the region. And he joins me to talk about what he saw, what he thinks, and where he's putting his money.
FAREED ZAKARIA, HOST: George Soros, pleasure to have you on.
GEORGE SOROS, SOROS FUND MANAGEMENT: Same here.
ZAKARIA: First on Ukraine. One of the things that many people recognized about you was that you, during the revolutions of 1989, funded a lot of dissident activities, civil society groups in Eastern Europe and Poland, the Czech Republic. Are you doing similar things in Ukraine?
SOROS: Well, I set up a foundation in Ukraine before Ukraine became independent of Russia. And the foundation has been functioning ever since. And it played a - an important part in events now.
http://cnnpressroom.blogs.cnn.com/2014/05/25/soros-on-russian-ethnic-nationalism/Sierra Leone: the final frontier?
By Carolyn Cohn NOVEMBER 16, 2009
Sierra Leone is holding an investment conference in London on Wednesday, showing even the world’s least developed countries can aspire to become emerging economies.
There are a few tentative signs of money going into the country, which was scarred by a 1991-2002 civil war.
CDC, the UK’s development finance arm, said last week it was investing $5 million in private equity in Sierra Leone, in small and medium-sized firms ranging from fishing to financial services.
Billionaire investor George Soros also said his economic development fund was making “significant commitments” to Sierra Leone.
Soros, Sierra Leone president Ernest Bai Koroma and former UK prime minister Tony Blair all feature at Wednesday’s conference.
Koroma has been in power for the last two years and investors see some stability, which is good for investment.
The government fired two senior ministers earlier this month in an attempt to improve its record on fighting corruption.
A consortium led by Anadarko Petroleum made an oil find off the Sierra Leone coast earlier this year, and the country has diamonds and gold, but analysts say there is little scope for investment outside the mining sector.
The country lacks the financial markets needed to attract investment flows, analysts say.
”It’s probably pre-pre-pre-emerging,” says one emerging market analyst.
But as investors start once more to chase higher returns around the world, could Sierra Leone yet become a “frontier” emerging market?
http://blogs.reuters.com/globalinvesting/2009/11/16/sierra-leone-the-final-frontier/ -
Anadarko Discovers Oil Offshore Sierra Leone
HOUSTON, TX, Nov 15, 2010 (MARKETWIRE via COMTEX) -- Anadarko Petroleum Corporation (NYSE: APC) today announced the Mercury-1 exploration well offshore Sierra Leone encountered approximately 135 net feet of oil pay in two Cretaceous-age fan systems. Mercury is the company's second deepwater test in the Sierra Leone-Liberian Basin and was drilled to a total depth of approximately 15,950 feet in about 5,250 feet of water.
"The Mercury well demonstrates that the stratigraphic trapping systems we've identified are working, and that the petroleum system is generating high-quality oil," Anadarko Sr. Vice President, Worldwide Exploration Bob Daniels said. "In the primary objective, the Mercury well encountered approximately 114 net feet of light sweet crude oil with a gravity of between 34 and 42 degrees API, with no water contact. An additional 21 net feet of 24-degree gravity crude was encountered in a shallower secondary objective.
http://www.anadarko.com/investor/pages/newsreleases/newsreleases.aspx?release-id=1496051
http://www.georgesoros.com/
Paralegal Justice Services Expand Across Sierra Leone
August 20, 2010 Open Society Justice Initiative
FREETOWN, Sierra Leone—The number of paralegals providing free basic justice services in Sierra Leone will more than double next month, as donors join with non-governmental organizations and community-based groups to create a nation-wide network of legal assistance...
The new offices can be found at the following locations:
Access to Justice Law Center: Kabala.
AdvocAid: Freetown, Waterloo and Kenema.
BRAC: Port Loko, Masiaka, and Lunsar.
Justice and Peace Commission/Caritas: Central Freetown, Waterloo, Hastings.
Methodist Church Sierra Leone: three chiefdoms in Bonthe district.
Timap for Justice: Kailahun district, Eastern Freetown, and four chiefdoms in Kenema district.
American philanthropist George Soros has committed to financially supporting the expansion of sustainable justice services in Sierra Leone for five years, as part of a wider global programme on legal empowerment of the poor, through the Open Society Foundations. GTZ is joining efforts as part of its project entitled “Promoting the Rule of Law and Justice in Sierra Leone.”
http://www.opensocietyfoundations.org/press-releases/paralegal-justice-services-expand-across-sierra-leone
http://metabiota.com/index.html
OUR GLOBAL PARTNERS
We work in partnership with local governments, health agencies, private sector firms and non-profit organizations to build effective teams, develop and implement innovative solutions that achieve high impact and long lasting results.
Africa
CAMEROON
Global Viral Cameroon
GABON
Centre International de Recherches Médicales de Franceville
Ministry of Health
Ministry of Water and Forests
DEMOCRATIC REPUBLIC OF CONGO
Institut National de Recherche Biomédicale (INRB)
Ministry of Health
Institut Congolais pour la Conservation de la Nature
Kinshasa School of Public Health
Lola ya Bonobo Sanctuary
SIERRA LEONE
Ministry of Health & Sanitation
Kenema Government Hospital
Ministry of Agriculture, Forestry and Food Security
Asia
CHINA
Guangdong Institute of Public Health Centers for Disease Control and Prevention of Guangdong Province
INDONESIA
Eijkman Institute for Molecular Biology
Europe
FRANCE
Institut de Recherche pour le Développement
USA
Black and Veatch Special Projects Corp.
Centers for Disease Control and Prevention
Columbia University
Department of Defense, Defense Threat Reduction Agency
Cooperative Biological Engagement Program
Department of Defense, ? /AIDS Prevention Program
Department of State, Biological Engagement Program
EcoHealth Alliance
Kansas State University
Smithsonian Institute
Southern Research Institute
Tulane University
University of California, Davis
University of California, Los Angeles
University of California, San Francisco
Childrens Hospital, Boston, Harvard Medical School
University of Louisville Research Foundation, Inc.
USAID
US Army Medical Research Institute of Infectious Diseases
Cherokee Nation Technology Solutions, LLC
Armed Forces Health Surveillance Center
International
World Health Organization
http://metabiota.com/global-partners.html -
Viral Hemorrhagic Fever Consortium
The Viral Hemorrhagic Fever Consortium was established in 2010 as a result of a five-year $15 million contract awarded to Tulane University by the National Institute of Allergy and Infectious Diseases (NIAID), which is part of the National Institute of Health (NIH). This contract was awarded for Tulane's ongoing efforts to treat and prevent Lassa Fever, a disease that threatens hundreds of thousands of lives annually in West Africa and is classified as a potential bioterrorism threat.
The goal of the Consortium is to undertand mechanisms related to the human immune response to Lassa virus infection. Specifically, by understanding what parts of the virus are recognized by the immune system, we can better understand mechanisms of antibody-mediated protection or pathogenesis in humans with Lassa Fever.
Tulane's previous efforts focused on the development of new recombinant proteins for Lassa virus and diagnostic products, which have shown to be extremely effective in clinical settings in Africa. The new NIH award enables research to move to the next level, allowing for focus to be shifted towards better treatment and ultimately prevention of Lassa fever altogether.
The Consortium is a collaboration between Tulane, Scripps Research Institute, Broad Institute, Harvard University, University of California at San Diego, University of Texas Medical Branch, Autoimmune Technologies LLC, Corgenix Medical Corporation, Kenema Government Hospital (Sierra Leone), Irrua Specialist Teaching Hospital (Nigeria) and various other partners in West Africa. Together they work on evaluating antibodies from patients who have been infected by Lassa virus and have subsequently recovered, to see if those antibodies might play a role in the development of a vaccine or treatment for the illness. The Consortium intends to expand this program to include other important infectious agents such as Ebola, Marburg and other Arenaviruses that are of great concern to public health and bioterrorism.
http://vhfc.org/consortium
Partnerships:
Autoimmune Technologies
Corgenix Medical Corporation (NASDAQ : CONX)
Kenema Government Hospital, Republic of Sierra Leone
Tulane University
University of Texas Medical Branch (UTMB)
Viral Hemorrhagic Fever Consortium (VHFC)
Vybion
http://www.zalgenlabs.com/partnerships.html
The Sabeti Lab, headed by Pardis Sabeti, is part of the FAS Center for Systems Biology at Harvard University, and maintains close ties to the Eli and Edyth Broad Institute of Harvard and MIT.
The goals of The Sabeti Lab are to use computational methods and genomics to understand mechanisms of evolutionary adaptation in humans and pathogens. We are pursuing these goals through 3 research foci:
1. Developing analytical and experimental methods to detect and investigate natural selection in the genome of humans and other species.
2. Examining host and viral genetic factors driving resistance to Lassa Fever in West Africa.
3. Examining signals of natural selection in pathogens, including Lassa virus, Ebola virus, and Plasmodium falciparum malaria to understand how they rapidly evolve, and studying their genetic diversity to guide long term intervention strategies.
http://sabetilab.org/about
The FAS Center for Systems Biology is an interdepartmental initiative at Harvard University
Our overall goal is to combine a variety of experimental and theoretical approaches to find general principles that help to explain the structure, behavior and evolution of cells and organisms. Our faculty and Fellows span a wide range of disciplines, including biology, physics, chemistry, mathematics, computer science, and engineering. We are the home of the Bauer Fellows program, the Bauer Core facilities, and faculty belonging to departments in the Faculty of Arts and Sciences. We are part of a university-wide initiative in systems biology, which also comprises the PhD program in Systems Biology and the Department of Systems Biology at Harvard Medical School. The Center is also one of the NIGMS National Centers of Systems Biology. and part of the NSF Physics of Living Systems graduate student Research Network.
To learn more about the center, click here.
http://sysbio.harvard.edu/csb/index.html -
Areas of Focus
The Broad Institute is committed to meeting the most critical challenges in biology and medicine. Broad scientists pursue a wide variety of projects that cut across scientific disciplines and institutions. Collectively, these projects aim to:
Assemble a complete picture of the molecular components of life. The Human Genome Project was only a first step in laying out the ”Periodic Table” of life. Broad Institute scientists are working to extend this knowledge by identifying all of the functional elements in the human genome and revealing how these working parts vary both in humans and other species.
http://www.broadinstitute.org/what-broad/areas-focus/areas-focusEbola 'out of control' in West Africa as health workers rush to trace 1,500 possible victims
Fear, mistrust of Western medicine and difficulties reaching remote areas mean hundreds of potentially infected people have not yet been found
By Mike Pflanz, West Africa Correspondent9:18AM BST 03 Jul 2014
Health workers carry the body of an Ebola virus victim in Kenema, Sierra Leone Photo: REUTERS
Hundreds of West Africans could be carrying the deadly Ebola virus and not know it, potentially infecting hundreds more, as cash-strapped governments and overwhelmed aid agencies struggle to contain the virus's spread.
At least 1,500 people have not yet been traced who are known to have come into contact with others confirmed or suspected to be infected with the haemorrhagic fever, Medecins Sans Frontieres (MSF) told The Telegraph.
Many more could be moving freely in the three countries battling the virus, Guinea, Liberia and Sierra Leone, but fear of the illness and mistrust of Western medicine means they refuse to come forward to speak to doctors.
The current outbreak is the worst ever. So far 467 people have died and health staff have identified at least 292 other suspected or confirmed cases.
http://www.telegraph.co.uk/news/worldnews/africaandindianocean/guinea/10942598/Ebola-out-of-control-in-West-Africa-as-health-workers-rush-to-trace-1500-possible-victims.htmlSierra Leone Samples: Ebola Evidence in West Africa in 2006
USAMRIID Providing On-site Laboratory Support to Current Outbreak
Analysis of clinical samples from suspected Lassa fever cases in Sierra Leone showed that about two-thirds of the patients had been exposed to other emerging diseases, and nearly nine percent tested positive for Ebola virus. The study, published in this month’s edition of Emerging Infectious Diseases, demonstrates that Ebola virus has been circulating in the region since at least 2006—well before the current outbreak.
http://www.usamriid.army.mil/press_releases/Randy_Final_EID_July_2014.pdf -
01. outbreaks of a virulent disease occur in Africa
02. people want to study it
03. ...
04. CONSPIRACY -
Wouldn't be surprised if it was true though stranger things have happened.
-
01. outbreaks of a virulent disease occur in Africa
02. people want to study it
03. ...
04. CONSPIRACY
Scientists were studying the Ebola (and other viruses) here in the U.S and in parts of West Africa before the outbreak occurred.
The scientists may have noble intentions, but in many instances the individuals who fund this research may have a different agenda.
-
true. i mean more in the sense that THIS outbreak occurred and people want to study it, not that there have never been prior outbreaks.Scientists were studying the Ebola (and other viruses) here in the U.S and in parts of West Africa before the outbreak occurred.
-
We never had Ebola in the US.
And the Texas border is wide open with people coming thru unchecked from all nations including Ebola infected nations. Border patrol is on complete stand down for some reason -
Reston ebolavirus is still Ebola. and Virgina and Texas are actually in the US.Judah Back wrote: »We never had Ebola in the US.
but i am pretty sure what he was saying was that it has been STUDIED in the US before, not that there have been outbreaks.
-
Ebola Outbreak: The Latest U.S. Government Lies. The Risk of Airborne Contagion?
By Prof Jason Kissner
Global Research, October 01, 2014
We begin with the Public Health Agency of Canada, which once (as recently as August 6) stated on its website that:
“In the laboratory, infection through small-particle aerosols has been demonstrated in primates, and airborne spread among humans is strongly suspected, although it has not yet been conclusively demonstrated (1, 6, 13). The importance of this route of transmission is not clear. Poor hygienic conditions can aid the spread of the virus.”
No more; the “airborne spread among humans is strongly suspected” language has been cleansed:
“In laboratory settings, non-human primates exposed to aerosolized ebolavirus from pigs have become infected, however, airborne transmission has not been demonstrated between non-human primates
Footnote1 Footnote10 Footnote15 Footnote44 Footnote45.
Viral shedding has been observed in nasopharyngeal secretions and ? swabs of pigs following experimental inoculation.”
Are we to suppose that very recent and ground-breaking research was conducted that indicated there is no longer reason to “strongly suspect” that airborne Ebola contagion occurs? Surely, the research was done three weeks ago, and we only need to wait another couple of days until the study is released for public consumption. Feel better now?
If not, perhaps the 9/30 words of the Centers for Disease Control accompanying the Dallas Ebola case will provide some solace. Or, perhaps those words just contain another pack of U.S. Government lies. Let’s investigate.
Before addressing the CDC’s Statement, we should articulate some pivotal Ebola Outbreak facts we’re apparently not supposed to mention or even think about, since they’ve been buried by the Government/MSM complex. So, consider this from an earlier Global Research contribution by this author, drawn from a 2014 New England Journal of Medicine article:
“Phylogenetic analysis of the full-length sequences established a separate clade for the Guinean EBOV strain in sister relationship with other known EBOV strains. This suggests that the EBOV strain from Guinea has evolved in parallel with the strains from the Democratic Republic of Congo and Gabon from a recent ancestor and has not been introduced from the latter countries into Guinea. Potential reservoirs of EBOV, fruit bats of the species Hypsignathusmonstrosus, Epomopsfranqueti, & Myonycteristorquata, are present in large parts of West Africa.18 It is possible that EBOV has circulated undetected in this region for some time. The emergence of the virus in Guinea highlights the risk of EBOV outbreaks in the whole West African subregion…
The high degree of similarity among the 15 partial L gene sequences, along with the three full-length sequences and the epidemiologic links between the cases, suggest a single introduction of the virus into the human population. This introduction seems to have happened in early December 2013 or even before.”
The take-home message is that we now confront a brand spanking new genetic variant of Ebola. Furthermore, we still have no idea at all how the “single introduction of the virus in the human population” of West Africa occurred. And, the current Ebola outbreak appears to be orders of magnitude more contagious than previous outbreaks. It also presents with a fatality count that far exceeds all previous outbreaks combined. But it’s certainly not airborne, so who cares about nit-picking details such as these!
In spite of the above facts, we are supposed to believe that all questions regarding the current Ebola outbreak can be answered with exclusive reference to what has occurred in connection with previously encountered—in terms of genetic composition—and known—in terms of initial outbreak source—Ebola episodes.
Here are a couple of questions. When was the last time an Ebola outbreak coincided with instructions to U.S. funeral homes on how to “handle the remains of Ebola patients”? Not to worry, since Alysia English, Executive Director of the Georgia Funeral Homes Association, is quoted (click preceding link) as saying “If you were in the middle of a flood or gas leak, that’s not the time to figure out how to turn it off. You want to know all of that in advance. This is no different.” So it’s just about being prepared, you see. Of course, nothing resembling this sort of preparation has ever transpired alongside any other Ebola outbreak in world history, so what gives now?
“Oh, it’s because we now have that Ebola case in Dallas.” True, but this response suffers from two fatal defects. First, we’re not supposed to worry about one tiny case as long as it’s in America, right, since according to the CDC on 9/30:
…there’s all the difference in the world between the U.S. and parts of Africa where Ebola is spreading. The United States has a strong health care system and public health professionals who will make sure this case does not threaten our communities,” said CDC Director, Dr. Tom Frieden, M.D., M.P.H. “While it is not impossible that there could be additional cases associated with this patient in the coming weeks, I have no doubt that we will contain this.”
-
If the U.S.’ strong health care system (which is apparently far superior to hazmat suits) is so effective at containment, what explains the funeral home preparations again? If U.S. containment procedures are so superb and the virus is no more contagious than before, what difference does it make whether the case is in Dallas, Texas or Sierra Leone? To be sure, maybe the answers to these questions are simple, and it’s just about corrupt money and the like.
However, the corrupted money explanation isn’t very plausible (at least on its own) either, for the very simple, and extremely disturbing, reason that the “funeral home preparations” article was first published on 9/29 at 3:36 PM PST—a day before the Dallas case was confirmed positive. Of course, this makes the following language at the very head of the article all the more eerie:
“CBS46 News has confirmed the Centers for Disease Control has issued guidelines to U.S. funeral homes on how to handle the remains of Ebola patients. If the outbreak of the potentially deadly virus is in West Africa, why are funeral homes in America being given guidelines?”
If the rejoinder is that “well, people thought the Dallas case might turn out positive”, the reply must be that there were several other cases, in places like Sacramento and New York, that might have turned out positive, but resulted in neither funeral home preparations nor a rash of CDC “Ebola Prevention” tips (wash those hands, since they’re running low on hazmat suits!)
Hopefully, you are in the mood for two more big CDC lies, because they really are quite important. From the 9/30 CDC statement: “People are not contagious after exposure unless they develop symptoms.” This is a lie for three basic reasons. First, the studies that inform the CDC’s professed certainty on this issue relied upon analyses of previous outbreaks of then-known known Ebola variants. The current strain, as stated here early on, is novel—genetically as well as geographically. Second, the distinction between “incubation” and “visible symptoms” is a continuum, not discrete in nature; a few droplets might not be rain, but they’re not indicative of fully clear skies either—so the boundary drawn by the CDC is, like nearly everything else the U.S. government does, arbitrary. Third, as even rank amateurs at statistics know, previous outbreaks have consisted of too few cases to confidently rule out small but consequential probabilities of asymptomatic transmission—completely leaving aside the fact that we have a new genetic variant of Ebola to deal with.
The last major CDC lie mentioned in this article is the claim, repeated ad nauseam, that “infrastructure shortcomings” and the like is wholly sufficient to explain the exponential increase in the number of cases presented by the current outbreak. We should believe that only when presented with well-designed multivariate contagion models that properly incorporate information about Ebola outbreaks and generate findings that socioeconomic differences as between West Africa and other regions of Africa (such as Zaire) alone can fully explain observed differences associated with the current outbreak. It seems to this author that we should strongly doubt that the current contagion can be fully explained without at some point invoking features of the novel genetic strain.
Dr. Jason Kissner is Associate Professor of Criminology at California State University. Dr. Kissner’s research on gangs and self-control has appeared in academic journals. His current empirical research interests include active shootings. You can reach him at crimprof2010[at]hotmail.com
http://www.globalresearch.ca/ebola-outbreak-the-latest-u-s-government-lies/5405584 -
I don't know if the west or any one group is spreading Ebola around intentionally but I lean against this belief because Ebola is so unpredictable and can spread quite easily (3 feet by air, and ? fluids being shared is enough).
If a group wanted to exterminate people intentionally, there are easier and faster ways to do it....more efficient as well, most people in the end survive Ebola. -
it is not actually spread "quite easily." that's the one good thing about Ebola.kingblaze84 wrote: »-because Ebola is so unpredictable and can spread quite easily (3 feet by air, and ? fluids being shared is enough).
-
it is not actually spread "quite easily." that's the one good thing about Ebola.kingblaze84 wrote: »-because Ebola is so unpredictable and can spread quite easily (3 feet by air, and ? fluids being shared is enough).
If Ebola is not spread quite easily, then why are people being quarantined for this disease? It can't be spread as easily as the common cold, which is good if that's what you mean -
because it CAN be spread and it's much more lethal than the average disease out there, so we want to stamp out the transmission ASAP? Ebola isn't airborne, is what i'm saying.kingblaze84 wrote: »If Ebola is not spread quite easily, then why are people being quarantined for this disease?
-
because it CAN be spread and it's much more lethal than the average disease out there, so we want to stamp out the transmission ASAP? Ebola isn't airborne, is what i'm saying.kingblaze84 wrote: »If Ebola is not spread quite easily, then why are people being quarantined for this disease?
I heard from 3 feet away it is, but some say it's not true. To be honest, I heard the 3 feet thing away from a conservative site, not sure if it means anything
Edit: Looks like you're right, I did some research and it can't be spread through the air. BUT people do sleep around and share fluids for all kinds of reasons, even sweaty hands is enough to spread the virus. So the virus can spread around easily in a way, people share drinks among friends and family all the time. -
plenty of conservatives losing their minds over Ebola, to be honestkingblaze84 wrote: »I heard from 3 feet away it is, but some say it's not true. To be honest, I heard the 3 feet thing away from a conservative site, not sure if it means anything
-
-
If the Ebola virus gets worse then what it already is, would ya'll favor a temporary ban on flights from western Africa? The virus is spreading supposedly
https://www.youtube.com/watch?v=kPGMPlEHLTA
